Skip to content

What does tacrolimus do to the immune system?

4 min read

Used in over 500,000 prescriptions in the U.S. in 2021, tacrolimus is a powerful immunosuppressive drug [1.3.3]. So, what does tacrolimus do to the immune system? It primarily works by decreasing the activity of T-cells to prevent organ rejection and treat certain autoimmune conditions [1.2.1, 1.2.2].

Quick Summary

Tacrolimus is an immunosuppressant that works by inhibiting calcineurin, which stops the activation and growth of T-cells [1.2.1, 1.3.1]. This action is crucial for preventing the rejection of transplanted organs and managing various T-cell-mediated autoimmune diseases [1.4.1, 1.4.3].

Key Points

  • Primary Function: Tacrolimus is an immunosuppressant drug that works by decreasing the activity of the immune system, primarily T-cells, to prevent organ rejection [1.2.2].

  • Mechanism of Action: It inhibits an enzyme called calcineurin, which blocks the activation of T-cells and the production of inflammatory signals like Interleukin-2 [1.2.1, 1.3.3].

  • Main Use: Tacrolimus is a cornerstone medication for preventing the rejection of transplanted organs, including the kidney, liver, heart, and lung [1.4.1, 1.4.6].

  • Autoimmune Treatment: It is also used to treat T-cell mediated autoimmune diseases, such as atopic dermatitis (eczema), vitiligo, and rheumatoid arthritis [1.4.3, 1.9.4].

  • Major Risks: Because it suppresses the immune system, tacrolimus increases the risk of serious infections and certain types of cancer, like lymphoma and skin cancer [1.2.2, 1.5.2].

  • Common Side Effects: Other common side effects include kidney problems, high blood pressure, new-onset diabetes, tremors, and headaches, requiring regular monitoring [1.5.2, 1.5.6].

  • Potency: Tacrolimus is 10 to 100 times more potent than cyclosporine, another common calcineurin inhibitor, and is often associated with lower acute rejection rates [1.3.1, 1.6.4].

In This Article

Tacrolimus, also known as FK-506, is a cornerstone medication in transplant medicine and a powerful tool for managing certain autoimmune disorders [1.3.1, 1.4.3]. It belongs to a class of drugs called calcineurin inhibitors, which are approximately 100 times more potent than the similar drug, cyclosporine [1.3.1, 1.6.3]. Its primary function is to suppress the body's immune response to prevent it from attacking a new organ or its own tissues [1.2.2, 1.4.6]. This suppression carries significant benefits but also requires careful management due to potential risks.

The Core Mechanism: T-Cell Inhibition

To understand what tacrolimus does to the immune system, it's essential to focus on its effect on T-lymphocytes, or T-cells. These are white blood cells that play a central role in orchestrating the immune response [1.2.1]. When the body detects a foreign entity, like a transplanted organ, T-cells are activated to attack it [1.4.6].

How Tacrolimus Intervenes

Tacrolimus disrupts this activation process at a molecular level [1.3.3]:

  1. Binding to FKBP12: Inside a T-cell, tacrolimus binds to a protein called FK506 binding protein (FKBP12) [1.3.1].
  2. Inhibiting Calcineurin: The newly formed tacrolimus-FKBP12 complex then binds to and inhibits an enzyme called calcineurin [1.3.3]. Calcineurin is a calcium-dependent phosphatase crucial for T-cell activation [1.3.1].
  3. Blocking NFAT: By inhibiting calcineurin, tacrolimus prevents the dephosphorylation of a transcription factor known as the Nuclear Factor of Activated T-cells (NFAT) [1.3.3].
  4. Halting Cytokine Production: This blockade stops NFAT from moving into the T-cell's nucleus, where it would normally switch on the genes responsible for producing interleukin-2 (IL-2) and other inflammatory cytokines [1.3.3]. IL-2 is a key signaling molecule that promotes the growth and proliferation of T-cells [1.3.3].

By stopping IL-2 production, tacrolimus effectively halts the T-cell-led immune assault, thereby preventing organ rejection or calming an autoimmune flare-up [1.3.5]. Studies also show that tacrolimus can inhibit other immune pathways, such as NF-κB activation, further contributing to its immunosuppressive effects [1.3.2, 1.3.4].

Clinical Applications of Immune Suppression

The primary use of tacrolimus is for the prophylaxis (prevention) of organ rejection in patients who have received a kidney, liver, heart, or lung transplant [1.2.2, 1.4.1]. By dampening the immune system, it allows the recipient's body to accept the new organ [1.4.6].

Beyond transplantation, tacrolimus is used for several T-cell-mediated autoimmune conditions [1.4.5]:

  • Topical Use: As an ointment (e.g., Protopic), it treats skin conditions like atopic dermatitis (eczema) and vitiligo by suppressing the localized immune response in the skin [1.2.6, 1.9.4, 1.9.5]. This is particularly useful on sensitive areas like the face where long-term steroid use is undesirable [1.9.4].
  • Systemic Use: Orally, it is used off-label to manage conditions like lupus nephritis, rheumatoid arthritis, myasthenia gravis, and Crohn's disease, especially when other treatments have failed [1.4.2, 1.4.3].

Risks and Side Effects of a Suppressed Immune System

While suppressing the immune system is therapeutically necessary in these contexts, it is not without risk. Patients taking tacrolimus must be monitored closely by a physician experienced in immunosuppressive therapy [1.2.2].

Major Concerns

  • Increased Risk of Infection: A weakened immune system is less capable of fighting off bacteria, viruses, and fungi. This increases the risk of serious, and sometimes fatal, infections [1.2.2, 1.5.2]. Patients are advised to watch for signs of infection like fever, cough, or flu-like symptoms [1.2.2].
  • Increased Risk of Cancer: Long-term immunosuppression is linked to a higher risk of developing certain cancers, particularly lymphoma (a cancer of the immune system) and skin cancer [1.2.2, 1.5.1]. Patients should use sun protection and undergo regular skin checks [1.2.3, 1.5.3].
  • Other Significant Side Effects: Tacrolimus can also cause kidney problems (nephrotoxicity), high blood pressure, high blood sugar (new-onset diabetes), high potassium levels, and neurological issues like tremors and headaches [1.5.2, 1.5.6]. Regular blood work is required to monitor drug levels and check for these toxicities [1.7.1].

Comparison with Cyclosporine

Tacrolimus and cyclosporine are both calcineurin inhibitors, but they have key differences [1.6.3].

Feature Tacrolimus Cyclosporine
Potency 10 to 100 times more potent than cyclosporine [1.3.1]. Less potent, requiring higher doses [1.6.6].
Organ Rejection Associated with lower rates of acute rejection and better graft survival in kidney and liver transplants [1.6.2, 1.6.4]. Higher rates of acute rejection compared to tacrolimus [1.6.4].
Side Effect Profile Higher incidence of new-onset diabetes and neurological side effects like tremors [1.6.1, 1.6.6]. Higher incidence of hypertension, high cholesterol, hirsutism (excess hair growth), and gum hyperplasia [1.6.1, 1.6.6].

Conclusion

In essence, tacrolimus acts as a powerful brake on the immune system by specifically targeting and inhibiting the activation and proliferation of T-cells [1.3.1]. It achieves this by blocking the calcineurin pathway, which is critical for producing the signals that drive an immune attack [1.3.3]. This targeted suppression is highly effective in preventing organ transplant rejection and managing a range of autoimmune diseases [1.4.2]. However, this benefit comes with the significant responsibility of managing the risks associated with a compromised immune system, including serious infections and an elevated risk of malignancy [1.2.2]. Therefore, treatment with tacrolimus requires continuous and careful medical supervision to maintain a delicate balance between efficacy and safety [1.2.2, 1.7.1].


For more information on the mechanism and uses of tacrolimus, a valuable resource is the National Center for Biotechnology Information (NCBI).

Frequently Asked Questions

The main function of tacrolimus is to suppress the body's immune system. It is primarily used to prevent the rejection of transplanted organs, such as the kidney, liver, heart, and lung, by preventing the immune system from attacking the new organ [1.2.2, 1.4.6].

Tacrolimus works by inhibiting an enzyme called calcineurin within T-cells, a type of white blood cell. This inhibition prevents the production of interleukin-2 and other key signals that are necessary for T-cell activation and proliferation, effectively calming the immune response [1.2.1, 1.3.3].

Yes, tacrolimus is considered a high-risk medication that should only be prescribed and supervised by an experienced doctor [1.2.2]. Its powerful immunosuppressive effects increase the risk of serious infections and certain cancers, such as lymphoma and skin cancer [1.2.2, 1.5.2].

Common side effects include tremors, headache, diarrhea, high blood pressure, nausea, kidney problems, and high blood sugar [1.5.2]. Due to its narrow therapeutic range, patients require regular blood tests to monitor drug levels and organ function [1.7.1].

Yes. Tacrolimus is also used to treat various autoimmune conditions. As a topical ointment, it is used for atopic dermatitis (eczema) and vitiligo [1.2.6, 1.9.4]. Orally, it may be used off-label for conditions like lupus nephritis, rheumatoid arthritis, and Crohn's disease [1.4.2, 1.4.3].

Both are calcineurin inhibitors, but tacrolimus is 10 to 100 times more potent [1.3.1]. Studies have shown tacrolimus to be superior in reducing acute organ rejection [1.6.2]. However, tacrolimus has a higher risk of causing diabetes and neurological issues like tremors, while cyclosporine is more associated with high blood pressure and gum problems [1.6.1, 1.6.6].

Yes, patients taking tacrolimus should avoid eating grapefruit and drinking grapefruit juice. Grapefruit can interfere with the metabolism of tacrolimus, leading to dangerously high levels of the drug in the blood [1.2.2, 1.5.2].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.